Acarbose Tablets is a medication used for the treatment of diabetes. It primarily contains acarbose, which works by slowing down the breakdown of sucrose to help control blood sugar levels. The medication is intended to be used in conjunction with dietary control. Common side effects include gastrointestinal bloating and bowel sounds. It is contraindicated in pregnant and breastfeeding women, as well as in patients under 18 years of age.
This document is the official package insert for Acarbose Tablets, marketed under the brand name Baetaoping® by Bayer Healthcare Co., Ltd. The medication contains acarbose as its main active ingredient and is intended for use in conjunction with dietary control to treat diabetes.
The text provides comprehensive instructions regarding dosage, administration methods (swallowing whole or chewing), and specific usage guidelines for different patient groups including the elderly. It details potential adverse reactions such as gastrointestinal bloating and diarrhea, lists contraindications like severe renal impairment, and outlines precautions for drug interactions. This manual is written in Chinese.
The starting dose is 50 mg taken three times a day.
The dose may be increased to 0.2 g taken three times a day.
The tablets should be swallowed whole immediately before a meal or chewed with the first few bites of food.